logo

QURE

uniQure·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

QURE fundamentals

uniQure (QURE) released its earnings on Nov 10, 2025: revenue was 3.70M (YoY +61.83%), missed estimates; EPS was -1.38 (YoY -51.65%), missed estimates.
Revenue / YoY
3.70M
+61.83%
EPS / YoY
-1.38
-51.65%
Report date
Nov 10, 2025
QURE Earnings Call Summary for Q3,2025
  • AMT-130 Regulatory Hurdle: FDA unexpectedly questions Phase I/II data sufficiency for BLA, delaying timeline.
  • Pipeline Progress: AMT-260 epilepsy and AMT-191 Fabry disease programs advancing, with data coming in H1 2026.
  • Financial Strength: $649M cash runway supports multi-regulatory engagement.
  • Key Risk: Dose-limiting toxicity in AMT-162 ALS program halts enrollment.
  • Global Strategy: EU/UK regulatory paths being explored post-US progress.
EPS
Revenue

Revenue & Expenses

QURE has released its 2025 Q3 earnings report, with revenue of 3.70M, reflecting a YoY change of 61.83%, and net profit of -80.53M, showing a YoY change of -81.46%. The Sankey diagram below clearly presents QURE's revenue sources and cost distribution.

Key Indicators

uniQure (QURE) key financial stats and ratios, covering profitability, financial health, and leverage.
uniQure (QURE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
uniQure (QURE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
uniQure (QURE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does uniQure (QURE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track uniQure (QURE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield